Meet the Professor
Dr. Zefei Jiang: our journey beyond the stars and seas
Translational Breast Cancer Research
2020;
1:
9
(10 April 2020)
Case Report
Pyrotinib for metastatic breast cancer after multi-anti-HER2 targeted therapy: a case report
Translational Breast Cancer Research
2020;
1:
8
(10 April 2020)
Case Report
Optimized first-line therapy for stage IV breast cancer brings long-term disease-free survival: a case report and biological analysis
Translational Breast Cancer Research
2020;
1:
7
(10 April 2020)
Review Article
Tumor microenvironment and future targets of immunotherapy in breast cancer
Translational Breast Cancer Research
2020;
1:
6
(10 April 2020)
Review Article
Why ACE—overview of the development of the subtype-selective histone deacetylase inhibitor chidamide in hormone receptor positive advanced breast cancer
Translational Breast Cancer Research
2020;
1:
5
(10 April 2020)
Guideline
CSCO BC guideline: updates for HER2 positive breast cancer in 2020
Translational Breast Cancer Research
2020;
1:
4
(10 April 2020)
Guideline
CSCO BC guideline: updates for hormone receptor-positive breast cancer in 2020
Translational Breast Cancer Research
2020;
1:
3
(10 April 2020)
Editorial
New therapeutic avenue of epigenetic modulations in cancer
Translational Breast Cancer Research
2020;
1:
2
(10 April 2020)
Foreword
Welcome to Translational Breast Cancer Research
Translational Breast Cancer Research
2020;
1:
1
(10 April 2020)
